|
TOP1P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.20829999999906E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.395100E-04 |
| Normal-vs-Stage2 |
4.417200E-04 |
| Normal-vs-Stage3 |
5.83119999999493E-05 |
| Normal-vs-Stage4 |
5.418300E-04 |
| Stage1-vs-Stage2 |
3.300000E-01 |
| Stage1-vs-Stage3 |
2.255000E-01 |
| Stage1-vs-Stage4 |
3.490800E-01 |
| Stage2-vs-Stage3 |
9.399800E-01 |
| Stage2-vs-Stage4 |
9.657800E-01 |
| Stage3-vs-Stage4 |
9.802200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.844970E-04 |
| Normal-vs-AfricanAmerican |
2.541000E-01 |
| Normal-vs-Asian |
1.864800E-03 |
| Caucasian-vs-AfricanAmerican |
1.826820E-01 |
| Caucasian-vs-Asian |
8.549800E-01 |
| AfricanAmerican-vs-Asian |
2.204400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78450000000363E-05 |
| Normal-vs-Female |
2.153600E-04 |
| Male-vs-Female |
3.046200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461530E-03 |
| Normal-vs-Age(41-60Yrs) |
6.07149999999335E-05 |
| Normal-vs-Age(61-80Yrs) |
1.18319999997674E-06 |
| Normal-vs-Age(81-100Yrs) |
3.696000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.545400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.445940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.389200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.211820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.266400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.328430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.257600E-01 |
| Classical-VS-Follicular |
1.44240000055085E-07 |
| Classical-VS-Other |
3.788400E-01 |
| Classical-VS-Normal |
7.280900E-03 |
| Tall-VS-Follicular |
8.563700E-03 |
| Tall-VS-Other |
5.909400E-01 |
| Tall-VS-Normal |
1.504120E-02 |
| Follicular-VS-Other |
3.672000E-01 |
| Follicular-VS-Normal |
4.56319981800846E-10 |
| Other-VS-Normal |
4.285700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.1044000004552E-07 |
| Normal-vs-N1 |
4.979800E-03 |
| N0-vs-N1 |
1.704600E-01 |
|
|
